COMP vs GILD · rev $5.63B vs P/E 18, rev $29.44B
Compass Inc (COMP) versus Gilead Sciences Inc (GILD) — a side-by-side from cached financials, not a winner call.
Compass Inc (COMP) is a real estate services company listed on US.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Latest reported COMP revenue for 2024-12-31 was $5.63B. Net income was -$154.5M. Revenue was up 15.2% from 2023-12-31 to 2024-12-31. COMP currently screens at market cap $3.35B.
Latest reported GILD revenue for 2025-12-31 was $29.44B. Net income was $8.51B. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
COMP currently screens at market cap $3.35B. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Not investment advice. Open the COMP and GILD stock pages for the full models.
Not investment advice.